2006
DOI: 10.1053/j.mppsy.2006.06.001
|View full text |Cite
|
Sign up to set email alerts
|

Psychological and drug therapies for post-traumatic stress disorder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

2012
2012
2015
2015

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 16 publications
1
2
0
Order By: Relevance
“…Freeman's claim that PTSD is commonly comorbid with other mental health disorders was also supported by the findings in the present study, as respondents who were classified as having PTSD symptoms also had significantly higher scores for generalised anxiety disorder (Freeman, 2006). However, the relationships between type of stalking and psychological distress gave a more complex picture.…”
Section: Discussionsupporting
confidence: 82%
See 1 more Smart Citation
“…Freeman's claim that PTSD is commonly comorbid with other mental health disorders was also supported by the findings in the present study, as respondents who were classified as having PTSD symptoms also had significantly higher scores for generalised anxiety disorder (Freeman, 2006). However, the relationships between type of stalking and psychological distress gave a more complex picture.…”
Section: Discussionsupporting
confidence: 82%
“…Other symptom clusters are the experiencing of avoidance and numbing, often linked to withdrawal or dependence behaviours such as alcohol or drug misuse (Avant, Davis, & Cranston, 2011). Comorbidity with disorders such as generalised anxiety disorder, as well as with substance dependence or misuse is common among individuals who have screened positive for PTSD (Freeman, 2006). It has been argued that the conflicting findings relating to symptom combination and factor structure (O'Hare, Shen, & Sherrer, 2007;Palmieri & Fitzgerald, 2005) might suggest that PTSD should be considered a spectrum disorder with symptoms distributed along a continuum (Friedman, Resick, & Keane, 2007).…”
Section: Traumamentioning
confidence: 99%
“…The preparation of these two types of drugs is closely connected. Researchers are studying the interactions of different neurotransmitters [103], neurohormones [104], neuromodulators [105], enzymes [106], second messengers [107], co-transporters [108, 109], ion channels [110], and receptor proteins [111] in the central and peripheral nervous systems to develop drugs to treat many different neurological disorders, including pain [112], neurodegenerative diseases such as Parkinson's disease [113] and Alzheimer's disease [114], psychological disorders [115], addiction [116], and many others.…”
Section: Nervous System Nanodrugsmentioning
confidence: 99%